Akari Therapeutics, Plc announced that Melissa Bradford-Klug will step down as company's Chief Operating Officer effective May 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +5.10% | +55.61% | +5.77% |
1st Jan change | Capi. | |
---|---|---|
+5.77% | 37.73M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- AKTX Stock
- News Akari Therapeutics, Plc
- Melissa Bradford-Klug to Step Down as Chief Operating Officer of Akari Therapeutics, Plc